<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01735539</url>
  </required_header>
  <id_info>
    <org_study_id>UNottingham F/3/2009</org_study_id>
    <nct_id>NCT01735539</nct_id>
  </id_info>
  <brief_title>Dysfunction of Nutritive Blood Flow as a Determinant of Anabolic Resistance With Age; the Role of Amino Acids in Modulating Muscle Metabolism</brief_title>
  <acronym>Ajinomoto1A</acronym>
  <official_title>Dysfunction of Nutritive Blood Flow as a Determinant of Anabolic Resistance in Older People; The Role of Essential Amino Acids in Modulating Muscle Protein Metabolism; Bolus vs. Pulse Feeding Strategies and the Ability of Arginine to Rejuvenate Microvascular Responsiveness.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Nottingham</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Nottingham</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators plan to measure changes in muscle protein metabolism in response to
      feeding, comparing between a single large essential amino acid (EAA) feed (the normal
      building blocks of protein) and the provision of the same dose in 4 smaller feeds at 45min
      intervals. The investigators will perform this study in healthy older (65-75y) and younger
      (18-28) men. The investigators will also explore how feeding affects muscle blood flow as
      this is important in the delivery of the nutrients we eat to the muscle where they are used.

      The investigators plan to supplement the feed with arginine, a safe and widely found
      non-essential amino acid, to explore if this can improve muscle blood flow.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We will provide a 15g mixed essential amino acid feed or 4 x 3.75g.

      There is sexual dimorphism thus initially we will just recruit males. Powering calculations
      dictate n=8 in each group.

      We will use well established stable isotope tracer techniques (with 13C6 Phenylalanine) to
      measure muscle protein synthesis and breakdown by Gas Chromatography - combustion - isotope
      ratio mass spectroscopy.

      We will measure leg blood flow by phase shift Doppler and muscle microvascular flow by
      contrast enhanced ultrasound.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>December 2011</start_date>
  <completion_date type="Anticipated">January 2014</completion_date>
  <primary_completion_date type="Actual">January 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Muscle Protein Synthesis (FSR, fractional synthetic rate, %/hr)</measure>
    <time_frame>Across 6hr study</time_frame>
    <description>We measure FSR when fasted and again 0-90, 90-180 and 180-240 post feed.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Muscle Protein Breakdown (MPB)</measure>
    <time_frame>Across 6hr study</time_frame>
    <description>MBP is measured during fasting and 0-90, 90-180 and 180-240mins post feed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Whole leg blood flow</measure>
    <time_frame>Across a 6hr study</time_frame>
    <description>We measure common femoral blood flow by doppler ultrasound when fasted and again 0-90, 90-180 and 180-240 post feed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle Microvascular Blood flow</measure>
    <time_frame>Across a 6hr study</time_frame>
    <description>We measure muscle microvascular flow using contrast enhanced ultrasound when fasted and again 0-90, 90-180 and 180-240 post feed.</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Old Age (Focus; Not a Recognized Condition)</condition>
  <arm_group>
    <arm_group_label>Old Bolus</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>15g EAA bolus</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Old Arginine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>15g EAA Bolus supplemented with 3g Arginine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Young Bolus</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>15g EAA bolus</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Young Pulse</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>4 x 3.75g Mixed EAA Pulses</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Old Pulse</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>4 x 3.75g Mixed EAA Pulses</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>15g EAA bolus</intervention_name>
    <description>Oral; in aqueous solution</description>
    <arm_group_label>Old Bolus</arm_group_label>
    <arm_group_label>Young Bolus</arm_group_label>
    <other_name>Mixed Essential Amino Acids</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>4 x 3.75g Mixed EAA Pulses</intervention_name>
    <description>Oral; in aqueous solution</description>
    <arm_group_label>Young Pulse</arm_group_label>
    <arm_group_label>Old Pulse</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>15g EAA Bolus supplemented with 3g Arginine</intervention_name>
    <description>Oral; in aqueous solution</description>
    <arm_group_label>Old Arginine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 65-75 or 18-28

        Exclusion Criteria:

          -  BMI &gt;30

          -  Diabetes

          -  Beta blocker or steroid use

          -  Established cerebrovascular, peripheral vascular or ischaemic heart disease.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philip J Atherton, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Nottingham</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Nottingham School of Graduate Entry Medicine and Health</name>
      <address>
        <city>Derby</city>
        <zip>DE23 6PF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 22, 2012</study_first_submitted>
  <study_first_submitted_qc>November 27, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 28, 2012</study_first_posted>
  <last_update_submitted>January 16, 2014</last_update_submitted>
  <last_update_submitted_qc>January 16, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 17, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>old age</keyword>
  <keyword>sarcopenia</keyword>
  <keyword>essential amino acid</keyword>
  <keyword>arginine</keyword>
  <keyword>contrast enhanced ultrasound</keyword>
  <keyword>muscle microcirculation</keyword>
  <keyword>muscle protein synthesis</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

